Cargando…
Implications of miRNAs dysregulation in amyotrophic lateral sclerosis: Challenging for clinical applications
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the selective degeneration of upper and lower motor neurons. Currently, there are no effective biomarkers and fundamental therapies for this disease. Dysregulation in RNA metabolism plays a critical role in the...
Autores principales: | Koike, Yuka, Onodera, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989161/ https://www.ncbi.nlm.nih.gov/pubmed/36895420 http://dx.doi.org/10.3389/fnins.2023.1131758 |
Ejemplares similares
-
Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis
por: Chen, YongPing, et al.
Publicado: (2016) -
Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis
por: Cheng, Yang-Fan, et al.
Publicado: (2023) -
Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis
por: Dudman, Jessica, et al.
Publicado: (2020) -
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
por: Chen, Qiao Yi, et al.
Publicado: (2021) -
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
por: Liu, Jinmeng, et al.
Publicado: (2022)